Diabetes:
Indications for: GLUCAGEN
Severe hypoglycemia in diabetics.
Adults and Children:
Give by IM, SC, or IV inj. Administer IM or SC inj into upper arm, thigh or buttocks. Hypoglycemia: <25kg or <6yrs (with unknown weight): 0.5mg. ≥25kg or ≥6yrs (with unknown weight): 1mg. May repeat dose if no response after 15mins. After responding and able to swallow, give oral carbohydrates.
GLUCAGEN Contraindications:
Pheochromocytoma. Insulinoma. Glucagonoma when used as a diagnostic test.
GLUCAGEN Warnings/Precautions:
Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma; risk of substantial increase in BP. If hypoglycemia develops after treatment, give oral or IV glucose. Conditions with insufficient hepatic glycogen (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Necrolytic migratory erythema (w. continuous infusion). As a diagnostic aid in diabetes or patients with cardiac disease; monitor blood glucose levels, BP, HR. Pregnancy. Nursing mothers.
GLUCAGEN Classification:
Antihypoglycemic.
GLUCAGEN Interactions:
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin. Potentiates anticholinergics; avoid concomitant use (during use as a diagnostic aid). Antagonized by insulin; monitor blood glucose (during use as a diagnostic aid).
Adverse Reactions:
Inj site reactions, nausea, vomiting, headache, dizziness, asthenia, pallor, diarrhea, somnolence, decreased BP.
How Supplied:
HypoKit—1 (w. syringe + diluent)
Miscellaneous diagnostic tests:
Indications for: GLUCAGEN
For use during radiologic examinations to temporarily inhibit movement of the GI tract.
Adult Dosage:
To relax the stomach, duodenal bulb, duodenum, small bowel: 0.2–0.5mg IV or 1mg IM. To relax the colon: 0.5–0.75mg IV or 1–2mg IM. After procedure, give oral carbohydrates to patients who have been fasting, if compatible.
Children Dosage:
Not established.
GLUCAGEN Contraindications:
Pheochromocytoma. Insulinoma. Glucagonoma when used as a diagnostic test.
GLUCAGEN Warnings/Precautions:
Instruct caregivers in proper use. Previously undiagnosed pheochromocytoma; risk of substantial increase in BP. If hypoglycemia develops after treatment, give oral or IV glucose. Conditions with insufficient hepatic glycogen (eg, starvation, adrenal insufficiency, chronic hypoglycemia); treat with glucose. Necrolytic migratory erythema (w. continuous infusion). As a diagnostic aid in diabetes or patients with cardiac disease; monitor blood glucose levels, BP, HR. Pregnancy. Nursing mothers.
GLUCAGEN Classification:
Diagnostic aid.
GLUCAGEN Interactions:
Transient increase in pulse and blood pressure may occur with beta-blockers. Loss of efficacy or may produce hypoglycemia with indomethacin. May potentiate the anticoagulant effect of warfarin. Potentiates anticholinergics; avoid concomitant use (during use as a diagnostic aid). Antagonized by insulin; monitor blood glucose (during use as a diagnostic aid).
Adverse Reactions:
Inj site reactions, nausea, vomiting, headache, dizziness, asthenia, pallor, diarrhea, somnolence, decreased BP.
How Supplied:
Diagnostic kit—1 (w. diluent); Single-dose vials—10
